IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 192 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,540 | -12.3% | 782,996 | -3.0% | 0.01% | 0.0% |
| Q2 2023 | $8,593 | -2.1% | 807,566 | -3.2% | 0.01% | -8.3% |
| Q1 2023 | $8,773 | -17.9% | 833,948 | -3.3% | 0.01% | -20.0% |
| Q4 2022 | $10,681 | -99.9% | 862,079 | -33.1% | 0.02% | -21.1% |
| Q3 2022 | $13,355,000 | -29.0% | 1,289,056 | -20.9% | 0.02% | -24.0% |
| Q2 2022 | $18,801,000 | -17.9% | 1,630,644 | -10.5% | 0.02% | 0.0% |
| Q1 2022 | $22,914,000 | +8.4% | 1,821,456 | +0.5% | 0.02% | +19.0% |
| Q4 2021 | $21,131,000 | -8.4% | 1,812,306 | +2.6% | 0.02% | -16.0% |
| Q3 2021 | $23,067,000 | -24.0% | 1,766,270 | -25.1% | 0.02% | -19.4% |
| Q2 2021 | $30,357,000 | +14.6% | 2,358,777 | -0.5% | 0.03% | +6.9% |
| Q1 2021 | $26,495,000 | -2.2% | 2,369,882 | -0.4% | 0.03% | -3.3% |
| Q4 2020 | $27,095,000 | +26.6% | 2,378,882 | -0.0% | 0.03% | +15.4% |
| Q3 2020 | $21,406,000 | -12.8% | 2,379,782 | 0.0% | 0.03% | -16.1% |
| Q2 2020 | $24,559,000 | +19.1% | 2,379,782 | +16.5% | 0.03% | 0.0% |
| Q1 2020 | $20,617,000 | -24.2% | 2,043,341 | 0.0% | 0.03% | -3.1% |
| Q4 2019 | $27,197,000 | +53.5% | 2,043,341 | -1.0% | 0.03% | +45.5% |
| Q3 2019 | $17,719,000 | -21.3% | 2,063,941 | +0.3% | 0.02% | -21.4% |
| Q2 2019 | $22,522,000 | +22.5% | 2,058,728 | +51.5% | 0.03% | +16.7% |
| Q1 2019 | $18,389,000 | +28.7% | 1,359,097 | -1.4% | 0.02% | +14.3% |
| Q4 2018 | $14,283,000 | -48.0% | 1,378,671 | -7.4% | 0.02% | -36.4% |
| Q3 2018 | $27,472,000 | -1.3% | 1,488,180 | +2.3% | 0.03% | -5.7% |
| Q2 2018 | $27,822,000 | +27.9% | 1,455,101 | +3.2% | 0.04% | +29.6% |
| Q1 2018 | $21,748,000 | +2.9% | 1,409,457 | 0.0% | 0.03% | +8.0% |
| Q4 2017 | $21,128,000 | -4.6% | 1,409,457 | +0.3% | 0.02% | -10.7% |
| Q3 2017 | $22,151,000 | -13.5% | 1,404,659 | +3.5% | 0.03% | -17.6% |
| Q2 2017 | $25,620,000 | +52.2% | 1,356,984 | +37.5% | 0.03% | +47.8% |
| Q1 2017 | $16,837,000 | +703.3% | 986,954 | +619.9% | 0.02% | +666.7% |
| Q4 2016 | $2,096,000 | -3.7% | 137,100 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $2,177,000 | +33.7% | 137,100 | +10.1% | 0.00% | +50.0% |
| Q2 2016 | $1,628,000 | +19.5% | 124,500 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $1,362,000 | -1.8% | 124,500 | +4.0% | 0.00% | 0.0% |
| Q4 2015 | $1,387,000 | +11.2% | 119,700 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $1,247,000 | -19.2% | 119,700 | -6.4% | 0.00% | 0.0% |
| Q2 2015 | $1,543,000 | – | 127,930 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |